Bibliometric analysis of metformin as an immunomodulator (2013–2024)

Bibliometric analysis of metformin as an immunomodulator (2013–2024)

BackgroundMetformin, the frontline treatment for diabetes, has considerable potential as an immunomodulator; however, detailed bibliometric analyses on this subject are limited.MethodsThis study extracted 640 relevant articles from the Web of Science (WOS) Core Collection and conducted visual analys...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tongyi Zhou, Yunfeng Yu, Liu Li, Xiu Liu, Qin Xiang, Rong Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	metformin immunomodulator tumor immune microenvironment immune checkpoint inhibition aging inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1526481/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
by: Jenny Ling-Yu Chen, et al.
Published: (2024-11-01)

Long-term disease control in dedifferentiated liposarcoma: a case report on trabectedin priming followed by PD-1 inhibition
by: Johannes M. Waldschmidt, et al.
Published: (2025-01-01)

Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
by: Yunyan Dai, et al.
Published: (2025-01-01)

Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
by: Li-Chun Lu, et al.
Published: (2023-04-01)

Metformin blocks BIK1-mediated CPK28 phosphorylation and enhances plant immunity
by: Yazhou Bao, et al.
Published: (2025-02-01)

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
by: Liubov A. Tashireva, et al.
Published: (2025-01-01)

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity
by: Ying Zhang, et al.
Published: (2025-12-01)

Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
by: Cheng Xu, et al.
Published: (2023-04-01)

The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
by: Wenhua Xia, et al.
Published: (2025-01-01)

“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
by: Barbara Seliger
Published: (2024-11-01)

Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study
by: Ping Liu, et al.
Published: (2025-01-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
by: Jiajun Zhou, et al.
Published: (2025-01-01)

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01)

Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC
by: Linxue Zhang, et al.
Published: (2025-01-01)

Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
by: Shishi Yu, et al.
Published: (2025-02-01)

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
by: Yuxiang Huang, et al.
Published: (2025-01-01)

Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)

A novel machine learning-based immune prognostic signature for improving clinical outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics and experimental study
by: Yuanchun Zhao, et al.
Published: (2025-01-01)

Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
by: Shi-liang Chen, et al.
Published: (2025-01-01)

Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
by: Tian-Hang Yu, et al.
Published: (2025-01-01)

Impaired ARID1A expression attenuated the immune response in gastric cancer via histone acetylation
by: Yu Tang, et al.
Published: (2025-01-01)

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
by: Pingping Feng, et al.
Published: (2025-01-01)

The success of the tumor immunotherapy: neutrophils from bench to beside
by: Meng Zhu, et al.
Published: (2025-01-01)

The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
by: Qingzhe Wang, et al.
Published: (2025-01-01)

Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01)

Comprehensive analysis of heat shock protein 110, 90, 70, 60 families and tumor immune microenvironment characterization in clear cell renal cell carcinoma
by: Wenjing Liao, et al.
Published: (2025-01-01)

Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma
by: Fushan Gao, et al.
Published: (2024-12-01)

Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC)
by: Iadalin Ryntathiang, et al.
Published: (2024-09-01)

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)

Resistance mechanisms to immune checkpoint inhibitors: updated insights
by: Besan H. Alsaafeen, et al.
Published: (2025-01-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
by: Geofrey F. Soko, et al.
Published: (2025-01-01)

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01)

Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
by: Yonghua Cai, et al.
Published: (2025-02-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer
by: Yi Zhao, et al.
Published: (2025-01-01)

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
by: Ning Zhang, et al.
Published: (2025-01-01)

The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy
by: Guandu Li, et al.
Published: (2025-12-01)

Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade
by: Victoria E. Stefan, et al.
Published: (2024-11-01)